Vimarsana
Biggest News Aggregation in the World

Page 45 - Drug Controller General News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Drug Controller General. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Drug Controller General Today - Breaking & Trending Today

Millions Suffer From Untreatable Rare Diseases While Medical Costs Skyrocket - Vimarsana News

Millions Suffer From Untreatable Rare Diseases While Medical Costs Skyrocket

HERNDON, VA (PRWEB) December 12, 2022 -- The economic burden of rare diseases has been vastly underestimated. A retrospective study of medical and insurance

Source: prweb.com
Bharat Biotech asked to provide more data on Covaxin for below 12-year-olds - Vimarsana News

Bharat Biotech asked to provide more data on Covaxin for below 12-year-olds

SEC has recommended restricted emergency use of Biological E's COVID-19 vaccine, Corbevax, in children aged 5-12 years

PGI deaths: 3 months on, victims' identity not revealed : The Tribune India - Vimarsana News

PGI deaths: 3 months on, victims' identity not revealed : The Tribune India

While the Central Drugs Standard Control Organisation (CDSCO) has claimed that an FIR could not be lodged against the drug manufacturing firm with the PGIMER, Chandigarh, failing to provide a detailed report on the death of six persons following the administration of Propofol injection, the hospital

Eli Lilly introduces Ramiven (abemaciclib) in India, for certain high-risk early breast cancer patients - Vimarsana News

Eli Lilly introduces Ramiven (abemaciclib) in India, for certain high-risk early breast cancer patients

Stay connected with Business News This Week for business news, news this week, news headlines, business news, health, education, startups

Eli Lilly introduces Ramiven for certain high-risk early breast cancer patients in India - Vimarsana News

Eli Lilly introduces Ramiven for certain high-risk early breast cancer patients in India

Abemaciclib is a CDK4/6 inhibitor which has now been approved for HR+ HER2 - node positive high risk early breast cancer